Next Article in Journal
Hept-6-en-1-yl Furan-2-carboxylate
Previous Article in Journal
Structural Modification of Epigallocatechin-3-gallate to (2R,3R)-5,7-dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl l-valinate in Four Steps
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Synthesis and Antibacterial Studies of a New Au(III) Complex with 6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One

1
Department of General and Inorganic Chemistry with Methodology of Chemistry Education, Faculty of Chemistry, University of Plovdiv, “Tzar Assen” Str. 24, 4000 Plovdiv, Bulgaria
2
Department of Organic Chemistry and Pharmacognosy, Faculty of Chemistry and Pharmacy, University of Sofia, 1 J. Bourchier Av., 1164 Sofia, Bulgaria
3
Department of Microbiology, University of Food Technologies, 26 Maritza Blvd., 4002 Plovdiv, Bulgaria
*
Author to whom correspondence should be addressed.
Molbank 2024, 2024(2), M1827; https://doi.org/10.3390/M1827
Submission received: 2 May 2024 / Revised: 13 May 2024 / Accepted: 15 May 2024 / Published: 24 May 2024

Abstract

:
This article describes the synthesis of a new metal complex using 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one. The compound was analyzed using several methods, including determining its melting point and employing UV-Vis, IR, ATR, 1H NMR, HSQC, and Raman spectroscopy for the free ligand. The metal complex was formed by combining aqueous solutions of metal salts with the ligand dissolved in DMSO and water, along with NaOH in a metal-to-ligand-to-base ratio of 1:4:2. The NMR signals of the ligand were assigned using 1H-1H COSY, DEPT-135, HMBC, and HMQC spectra. Furthermore, the compound’s antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as yeasts, was assessed.

1. Introduction

Uracil, a fundamental pyrimidine derivative inherent in nucleic acids [1], assumes pivotal roles owing to its presence as a pyrimidine base with binding sites at the N1, N3, O2, and O4 atoms. Its significance and functionality extend to the enzyme structure and various medicinal applications. Notably, since 1942, 2-thiouracil has found utility in inhibiting thyroid hormone biosynthesis and treating Graves’ disease [2], whereas methylthiouracil serves as a recognized antithyroid drug.
In exploring the chemical versatility and practical applications of uracil derivatives, previous studies have provided valuable insights. Oladipo and Isola conducted an extensive review on uracil’s coordination possibilities and highlighted practical applications of some of its complexes [3]. Similarly, Masoud et al. delved into the complexing properties and biological activities of nucleic acids [4]. Meanwhile, recent contributions by Marinova and Tamahkyarova shed light on the synthesis and biological activities of metal complexes involving 2-thiouracil and its derivatives [5]. Furthering the exploration of uracil derivatives, Bomfim et al. synthesized Ru(II) complexes with 6-methyl-2-thiouracil as potential antileukemic agents [6]. The biological activities of 2-thiouracil and its metal complexes vary widely, with some being utilized as agents to combat tuberculosis and arthritis, while others exhibit bactericidal and fungicidal properties [3,4,5,7,8].
Recent advancements have also uncovered novel Cu(II) complexes of 6-methyl-2-thiouracil, highlighting the compound’s versatility in metal ion coordination through its oxygen, sulfur, and nitrogen atoms [9]. The possible means of coordination of metal ions with 6-methyl-2-thiouracil are given in Figure 1 and Figure 2. Different variants of chelating or bridge coordination are presented in Figure 3 and Figure 4.
Additionally, Fernández-Moreira et al. studied the anticancer properties of gold complexes with various bioligands [10]. Biocompatible citrate-reduced gold nanoparticles (AuNPs) were modified with a biologically active substance, 2-thiouracil (2-TU), with prospective anticancer properties [11]. The inhibitory effects on cell proliferation of AuNPs, 2-TU, and 2-TU-AuNPs were evaluated using a 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay in the MDA-MB-231 breast cancer cell line. It was demonstrated that AuNPs substantially boosted the inhibitory effect on cell proliferation of 2-TU [11]. Various gold(I), gold(III), and silver(I) metal complexes have been synthesized and their cytotoxicity has been studied [12]. These collective efforts underscore the chemical significance of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its derivatives, showcasing their potential coordination modes with metal ions.
The objective of the current study is to synthesize, characterize the structure, and investigate the biological properties of a novel gold complex of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and to contribute to the understanding of how the coordination of this ligand with gold affects its biological activity, potentially paving the way for the development of new therapeutic agents with targeted antimicrobial or cytotoxic properties.

2. Results and Discussion

The verification of the structure of the metal complex through IR analysis involves comparing the IR spectra of the free ligand with that of its metal complex. Selected experimental data from the IR spectra of the complex with the general formula AuL and of the free ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L) are presented in Table 1, showing characteristic absorption bands in wavenumbers (cm−1).
In the IR spectrum of the free ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L), bands at 3115 cm−1 and 3080 cm−1 are observed, corresponding to the stretching vibrations of N-H groups. These bands in the IR spectrum of the Au(III) complex show no significant change. Additionally, the IR bands of the free ligand at 1676 cm−1 and 1242 cm−1 are attributed to the stretching vibrations of the C4=O and C2=S groups, respectively. In the gold complex, these stretching vibrations are shifted to lower frequencies by 34 cm−1 for C4=O and to higher frequencies by 30 cm−1 for C2=S compared to the free ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L). This shift indicates the participation of the C4=O and C2=S groups of the ligand in coordinating with the Au(III) ion in the complex.
The highest points in the UV spectra of the free ligand were observed at the wavelengths λmax = 257 nm and 292 nm. In the electronic spectra of the gold complex, peaks were detected at 257 nm, 272 nm, and 292 nm. We conducted an initial UV analysis of the ligands in dimethyl sulfoxide at room temperature. The spectrum of the ligand is almost identical to the spectrum of the complex. The spectrum of the gold complex exhibited a minor peak around 272 nm, attributed to the electron transition from non-bonding orbitals to π* orbitals in the ligand. The primary absorption peak in the spectra resulted from the π → π* electron transition in the ligand. Any d–d transitions, if present, were part of the broad experimental band and overlapped with the ligand’s spectrum.
The gold complex is stable in air and moisture, and it has limited solubility. The reaction of the ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L) with the transition metal ion resulted in a 56% yield of a stable solid compound. The synthesized complex exhibits a yellow-orange color and is sparingly soluble in DMSO and DMF, but insoluble in water, THF, ethanol (C2H5OH), ethyl acetate (EtOAc), and cyclohexane (C6H12). Analytical data, including the yield percentages of the gold complex, are presented in Table 2.
The 1H NMR spectrum of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L) displays four signals, including a singlet at 12.29 ppm corresponding to H-1 and H-3 (overlapping resonances) [8]. The olefin proton is observed at 5.68 ppm (H-5), and the signal at 2.06 ppm is assigned to H-1′. These assignments were confirmed through analysis using 1H-1H COSY, 1H-broadband decoupled 13C-NMR, DEPT-135, and HMBC spectra, as detailed in Table 3 [8]. You can see the spectra in the Supplementary Materials.
The characterization of the gold complex in solution was obstructed by its low solubility in various solvents without heating, including DMSO. It is known that DMSO can not only be a solvent but also a ligand in the complexation, and upon heating can displace another ligand, leading to the decomposition of the complex. In fact, this is exactly what we observe when trying to dissolve a sample of the complex in DMSO-d6 at a high temperature for NMR. The NMR spectra of this sample showed the presence of free ligands, but no complex. Another sample was prepared via the gentle heating of a small quantity of the complex in DMSO-d6. The 1H and 13C NMR spectra of the AuL complex in DMSO-d6 solution are given in Figure 5 and Figure 6. In the 1H NMR spectrum of the complex, signals at 2.01, 5.31, 10.8, 10.9 ppm are observed. These signals are characteristic of 6-methyluracil (6-MeU) and not of 2-thiouracil derivatives. It is known that tetrahydropyrimidine-2,4-diones can be obtained through the desulfurization of 2-thioxo-1,2,3,4-tetrahydropyrimidin-4-ones in the presence of a base [13]. Since our complex synthesis is carried out in the presence of NaOH, it is not unexpected that some of the 6-Me-2-Tu is converted to 6-MeU and this is in agreement with the data reported by Novakov et al. [13]. In the 13C NMR solution spectrum of the complex, the signals at 174.09 ppm and 160.60 ppm correspond to the C=S and C=O groups, respectively. This indicates a decrease in the chemical shift of 1.78 ppm for the C=S resonance and 0.46 ppm for the C=O signal. These shifts suggest the involvement of the C=S and C=O groups of the ligand in coordination with the gold. Additionally, the signal at 174.09 ppm looks broader and has lower intensity compared with the same signal in the ligand spectrum. The signal for the C-5 carbon suffers the same broadening, which suggests spatial proximity to the binding site. The 1H and 13C NMR spectral data in the solution of the complex compared with the free ligand are given in Table 4.
However, solid-state NMR spectroscopy provides better distinction between the complex and the free ligand, as illustrated in Figure 7. The 13C NMR spectrum of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one obtained using the cross-polarization (CP) experiment reveals five distinct signals. Two of these signals are observed at chemical shifts of 174.6 ppm and 163.0 ppm, corresponding to the carbon atoms in the C=S (thione) and C=O (ketone) functional groups, respectively. Detailed chemical shift data are summarized in Table 5.
In the 13C NMR solid-state spectrum of AuL, there are a lot of signals, as can be seen from Table 5. There is a set of signals corresponding to the starting ligand (Figure 7). As can be seen from the signals corresponding to C-5, there are at least four more signals arising either from different coordination of the ligand, the presence of more than one ligand in the complex with different coordination, or because of different crystallization forms of the complex. The signals at ca. 41 ppm unambiguously show the presence of DMSO in the outer coordination sphere of the Au. There is a shift and a split in the signals for C=S and C=O, which shows that the C=S and C=O groups of the ligand participate in the coordination with the gold.
The ATR spectrum of a sample of the recently prepared AuL was measured to check if the coordination water was present in the complex. The ATR spectrum showed no trace of water in the complex. After recording the ATR spectrum again after the sample was allowed to stand for a while, we found the presence of water, which is in agreement with the results obtained by NMR.
Elemental analysis results for the metal ion were obtained using microwave plasma-atomic emission spectrometry. This result can be utilized to determine the tentative average composition of the complex. Considering that the ratio of ligand to 6-MeU is approximately 4:1 (1H NMR) and the presence of water and DMSO in the sample, we can propose the following tentative formulas for the complexes, as presented in Table 6.
Various metal complexes demonstrate a monodentate coordination mode with 2-thiouracil derivatives, binding primarily through the sulfur (S) atom. Examples include the Au(III), Pt(II), and Pd(II) complexes [11,12,14] (refer to Figure 1). The Pt(II) and Pd(II) complexes with 6-tert-butyl-2-thiouracil reported by Golubyatnikova et al. highlight sulfur as the primary coordinating atom in these complexes [14]. In the case of the Au(III)L complex, based on the experimental data acquired, we suggest a monodentate coordination via the S atom and/or monodentate coordination via the O atom. Specifically, we propose that two ligands participate in the coordination via the S2 atoms, while another two ligands coordinate via the O4 atoms (Figure 8).
6-Methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one exhibited the strongest activity against Enterococcus faecalis ATCC 19433 and Candida albicans ATCC 10231. No activity was detected against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 8739 and Saccharomyces cerevisiae. In the inhibition zones of the rest of the test microorganisms, except for Pseudomonas aeruginosa ATCC 9027, single-cell colonies were observed, which is a sign that some of the cells of the microorganisms were not sensitive to the tested concentration of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one. The complex of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one with Au(III) showed a different antimicrobial spectrum. Unlike the ligand, it was active against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 8739 and Saccharomyces cerevisiae, and had no effect on Proteus vulgaris G and Listeria monocytogenes ATCC 8787. Only in the inhibition zone of Klebsiella pneumoniae ATCC 13883 were single-cell colonies detected. The highest activity was expressed against S. aureus, and the lowest was expressed against E. coli ATCC 8739, B. subtilis, and S. cerevisiae. It is established that Au(III) has antimicrobial activity [15,16] and its addition to the ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one broadened its antimicrobial spectrum and increased its activity against S. aureus and K. pneumoniae.

3. Materials and Methods

The free ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one was purchased from Aldrich Chem. The metal salts NH4[AuCl4].H2O (Aldrich Chem) and solvents used for synthesis of the complexes were of high purity, generally equal to A.C.S. grade and were suitable for use in many laboratory and analytical applications.

3.1. Spectral Measurements

Absorption spectra were registered on a UV-30 SCAN ONDA UV/Vis/NIR spectrophotometer from 200 to 1000 nm. The IR spectra of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its complex were registered in KBr pellets on a Bruker FT-IR VERTEX 70 spectrometer from 4000 cm−1 to 400 cm−1 at a resolution of 2 cm−1 with 25 scans. The Raman spectra of the compound (the stirred crystals placed on an aluminum disc) were measured on a RAM II (Bruker Optics, Ettlingen, Germany) with a focused laser beam of d:YAG laser (1064 nm) from 4000 to 100 cm−1 at a resolution of 2 cm−1 with 25 scans. Additionally, the ATR (Madison, WI, USA) spectrum of the complex was measured (MIRacle Single reflection, PIKE technology) to check if the coordination water was present. The NMR spectra of the ligand were registered on a Bruker Avance II NMR spectrometer operating at 600.130 and 150.903 MHz for 1H and 13C, respectively, using the standard Bruker software. The NMR spectra of the metal complex were measured on a Bruker Avance III HD spectrometer operating at 500.130 and 125.76 MHz for 1H and 13C, respectively, equipped with a tunable multinuclear BBO probe-head for the measurements in solution state and with a 2.5 mm Cross-Polarization Magic Angle Spinning (CPMAS) probe-head for the solid-state experiments. CP MAS and Cross-Polarization with Polarization Inversion (CPPI) MAS spectra were recorded at an MAS speed of 15 kHz and α-glycine was used as an external reference (α-glycine carbonyl C—176.03 ppm). Measurements were carried out at ambient temperature.

3.2. Antimicrobial Assay

The antimicrobial activity of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its complex with Au(III) against various microorganisms was evaluated using the agar diffusion method. The tested microorganisms included Gram-positive bacteria such as Enterococcus faecalis ATCC 19433, Staphylococcus aureus ATCC 25923, Listeria monocytogenes ATCC 8787, Bacillus subtilis ATCC 6633, and Bacillus cereus ATCC 11778, as well as Gram-negative bacteria including Escherichia coli ATCC 8739, Salmonella enterica subsp. enterica ser. Enetritidis ATCC 13076, Pseudomonas aeruginosa ATCC 9027, Proteus vulgaris G, and Klebsiella pneumoniae ATCC 13883 and the yeasts Candida albicans ATCC 10231 and Saccharomyces cerevisiae. The procedure involved spreading a suspension of each test microorganism (106 cfu/cm3) onto specific nutrient agar media. Wells with a 7 mm diameter were created in the agar, and 50 μL of the tested substance solution (10 mg/cm3 in DMSO) was added to each well. The Petri dishes were then incubated at appropriate temperatures (37 °C for bacteria and C. albicans, and 30 °C for S. cerevisiae) for 24–48 h. After incubation, the inhibition zones around each well were measured, with zones larger than 7 mm considered as zones of inhibition. Each test was performed in triplicate, and the results were reported as mean values of the inhibition zone diameters. This methodology allowed for the assessment of the antimicrobial effectiveness of both 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its Au(III) complex against a range of pathogenic microorganisms.

4. Experimental Part

4.1. Synthesis and Characterization

4.1.1. Synthesis of Au(III) Complex of 6-Methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one—General Procedure

The metal complex was synthesized by combining aqueous solutions of the metal salt with the ligand dissolved in a mixture of DMSO and water, along with NaOH, in a metal-to-ligand-to-base ratio of 1:4:2. This process resulted in the formation of a non-charged complex, observed as a yellow-orange precipitate. The precipitate was then isolated by means of filtration, washed multiple times with water, and subsequently dried over CaCl2 for a period of 2 weeks.
The aqueous solution containing 71.4 mg (0.2 mmol) of NH4[AuCl4].H2O metal salt in 10 mL of water was added dropwise to a solution of 113.7 mg (0.8 mmol) of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one in 5 mL of DMSO. The ligand solution had been previously alkalized with an aqueous solution of sodium hydroxide, consisting of 16.0 mg (0.4 mmol) of NaOH in 5 mL of water.
The metal complex was obtained following a previously described procedure [7,8], with variations in the reaction duration (specifically 24 h for the gold(III) complex) and/or utilizing various solvents [6,14,17,18,19].

4.1.2. Spectral Data of the Free Ligand and Its Metal Complex

  • UV-Vis (DMSO) of L: λmax= 257, 292 nm
IR (cm−1) of L: 3115 (NH), 3080 (NH), 3014 (=CH), 2932 (CH3), 2890 (CH3), 2580, 2407, 1920, 1893, 1863, 1754, 1698, 1676 (C=O), 1637, 1560, 1423, 1384, 1349, 1242 (C=S), 1200, 1194, 1167, 1043, 1032, 993, 962, 933, 874, 838, 808, 729, 656, 598, 580, 553, 548, 513, 457, 416.
Raman (cm−1) of L: 3085 (NH), 2921, 1635, 1558, 1419, 1382, 1353, 1245 (C=S), 1199, 1177, 1043, 985, 961, 931, 834, 789, 657, 597, 554, 512, 458, 258, 214.
Raman spectra of gold complex could not be measured; the samples burned at 1 mW.
  • UV-Vis (DMSO) of Au(III) complex: λmax= 257, 272, 292 nm
IR (cm−1) of Au(III) complex: 3447, 3188, 3109, 3089, 2926, 2870, 1698, 1641, 1595, 1556, 1422, 1383, 1349, 1271, 1241, 1199, 1194, 1166, 1030, 838,809, 655, 626, 597, 552, 513, 458.
ATR (cm−1) of Au(III) complex: 3086, 2882, 1636, 1583, 1549, 1418, 1383, 1350, 1265, 1241, 1194, 1165, 1029, 951, 932, 907, 871, 833, 805, 744, 655, 624.
1H-NMR of Au(III) complex: 12.59 (br. s, 2H, NH), 5.81 (s, 1H, H-5), 2.55 (H-DMSO), 2.11 (s, 3H, H-1′).
13C-NMR of Au(III) complex: 174.09 (C=S), 160.60 (C=O), 153.28 (C-6), 104.84 (C-5), 40.31 (C-DMSO), 18.11 (C-1′)

4.1.3. Microwave Plasma—Atomic Emission Spectrometry (MP-AES) Determination of Au in the Complex

Samples with a mass of 20.0 mg were weighed out on an analytical balance and dissolved with 5 mL of aqua regia, comprising 65% nitric acid, p.a. (Chem-Lab, NV, Zedelgem, Belgium) and nitric and 37% hydrochloric acid, p.a. (Fluka AG, Buchs, Switzerland) for the Au complex. A blank solution was prepared as well. After appropriate dilution, the concentration of Au was determined by MP-AES 4200 (Agilent technologies, Santa Clara, CA, USA). Calibration standards were prepared from an Au monoelemental standard solution in 2% HCl. Conventional MP-AES operating conditions were used. The analyte was measured on three emission lines for the estimation of potential spectral interferences, i.e., 242.795 nm, 267.595 nm, and 312.278 nm. Five replicates and 5 s measurement were applied for all lines.

4.2. Antimicrobial Activity of Au(III) Complex of 6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One

The antimicrobial activity of the Au(III) complex of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one was evaluated and compared with the activity of the ligand 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one itself. The experimental results are summarized in Table 7.

5. Conclusions

This paper describes the synthesis of a novel complex of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one with gold(III). The structure of the new complex is elucidated through various analytical techniques, including melting point analysis, UV-Vis and IR spectroscopy, ATR, as well as solution- and solid-state NMR and Raman spectroscopy for the free ligand. Based on the spectral data obtained, we propose the coordination binding sites of the ligands within the complex. Two molecules of the ligand acted via oxygen atom and two through sulfur atom in the coordination of gold ions. In addition, we observed a solvent molecule in the composition of the complex, as indicated by the signals at 2.54 ppm and 40.31 ppm in the 1H and 13C NMR spectra of the complex solution. The ATR spectrum shows the presence of water, which is in agreement with the results obtained by NMR. This observation underscores the potential structural complexity and unique properties of the synthesized gold(III) complex.
The antimicrobial activity of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its complex with Au(III) was investigated against Gram-negative, Gram-positive bacteria, and yeasts. The addition of Au(III) broadened the antimicrobial spectrum of the ligand and it exhibited its highest activity against S. aureus.

Supplementary Materials

The following supporting information can be downloaded online: The following supporting information can be downloaded online: Figure S1. Structure of the ligand 6-methyl-2-thiouracil; Figure S2. The 1H NMR spectrum of the ligand, 6-methyl-2-thiouracil; Figure S3. 1H-broadband decoupled 13C-NMR spectrum of the ligand, 6-methyl-2-thiouracil; Figure S4. The DEPT-135 spectrum of 6-methyl-2-thiouracil; Figure S5. The 1H-1H COSY NMR spectrum of the ligand, 6-methyl-2-thiouracil; Figure S6. The HMQC NMR spectrum of the ligand, 6-methyl-2-thiouracil; Figure S7. The HMBC NMR spectrum of the ligand, 6-methyl-2-thiouracil; Figure S8. The Raman spectrum of 6-methyl-2-thiouracil; Figure S9. The IR spectrum of 6-methyl-2-thiouracil; Figure S10. The UV-Vis spectra of free ligand (orange) and its complex with gold (blue); Figure S11. The IR spectrum of the gold complex; Figure S12. The ATR spectrum of Au(III) complex; Figure S13. The IR spectrum of the complex, Au(III) with 6-methyl-2-thiouracil (red) and ligand (blue); Figure S14. 13C CP MAS of 6-methyl-2-thiouracil acquired at 15 kHz; Figure S15. 13C CP MAS of Au(III) complex acquired at 15 kHz; Figure S16. 13C CPPI MAS of Au(III) complex acquired at 15 kHz.

Author Contributions

Conceptualization, P.M. and D.B.; methodology, P.M.; formal analysis, N.B., D.B. and A.S.; investigation, D.B., A.S. and N.B.; resources, N.B.; data curation, P.M.; writing—original draft preparation, P.M. and N.B.; writing—review and editing, P.M. and N.B.; supervision, P.M.; funding acquisition, P.M. All authors have read and agreed to the published version of the manuscript.

Funding

We acknowledge the financial support from the Fund for Scientific Research of the Plovdiv University, project CП 23-XФ-006.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Acknowledgments

We acknowledge the financial support from the Fund for Scientific Research of the Plovdiv University, project CП 23-XФ-006 with project administration, Slava Tsoneva, S.T.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Garrett, R.H.; Grisham, C.M. Principles of Biochemistry with a Human Focus; Brooks/Cole Thomson Learning: Pacific Grove, CA, USA, 2001; p. 939. ISBN 0-03-097369-4. [Google Scholar]
  2. Astwood, E.B. The chemical nature of compounds which inhibit the function of the thyroid gland. J. Pharmacol. Exp. Ther. 1943, 78, 79–89. [Google Scholar]
  3. Oladipo, M.A.; Isola, K.T. Coordination Possibility of Uracil and Applications of Some of Its Complexes: A Review. Res. J. Pharm. Biol. Chem. Sci. 2013, 4, 386–394. [Google Scholar] [CrossRef]
  4. Masoud, M.S.; Ramadana, M.S.; Ramadana, A.M.; Al-Saify, M.H. Complexing Properties and Applications of Some Biologically Active Nucleic Acid Constituents. Int. J. Innov. Res. Technol. Sci. Eng. 2020, 6, 23–39. Available online: https://ijisset.org/storage/Volume6/Issue6/IJISSET-060524.pdf (accessed on 14 May 2024).
  5. Marinova, P.E.; Tamahkyarova, K.D. Synthesis and Biological Activities of Some Metal Complexes of 2-Thiouracil and Its Derivatives: A Review. Compounds 2024, 4, 186–213. [Google Scholar] [CrossRef]
  6. Bomfim, L.M.; de Araujo, F.A.; Dias, R.B.; Sales, C.B.S.; Gurgel Rocha, C.A.; Correa, R.S.; Soares, M.B.P.; Batista, A.A.; Bezerra, D.P. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells. Sci. Rep. 2019, 9, 11483–11500. [Google Scholar] [CrossRef] [PubMed]
  7. Marinova, P.; Tsoneva, S.; Frenkeva, M.; Blazheva, D.; Slavchev, A.; Penchev, P. New Cu(II), Pd(II) and Au(III) complexes with 2-thiouracil: Synthesis, Characteration and Antibacterial Studies. Russ. J. Gen. Chem. 2022, 92, 1578–1584. [Google Scholar] [CrossRef]
  8. Marinova, P.; Hristov, M.; Tsoneva, S.; Burdzhiev, N.; Blazheva, D.; Slavchev, A.; Varbanova, E.; Penchev, P. Synthesis, Characterization, and Antibacterial Studies of New Cu(II) and Pd(II) Complexes with 6-Methyl-2-Thiouracil and 6-Propyl-2-Thiouracil. Appl. Sci. 2023, 13, 13150–13168. [Google Scholar] [CrossRef]
  9. Skrobanska, M.; Zabiszak, M.; Taras-Goslinska, K.; Nowak, M.; Kaczmarek, M.T.; Frymark, J.; Michalska, D.; Jastrzab, R. Potentiometric and spectroscopic studies of the complex formation in the 6-methyl-2-thiouracil and copper(II) ion system. Polyhedron 2022, 223, 115964–115970. [Google Scholar] [CrossRef]
  10. Fernández-Moreira, V.; Herrera, R.P.; Concepción Gimeno, M. Anticancer properties of gold complexes with biologically relevant ligands. Pure Appl. Chem. 2018, 91, 247–269. [Google Scholar] [CrossRef]
  11. Lorenzana-Vázquez, G.; Pavel, I.; Meléndez, E. Gold Nanoparticles Functionalized with 2-Thiouracil for Antiproliferative and Photothermal Therapies in Breast Cancer Cells. Molecules 2023, 28, 4453–4466. [Google Scholar] [CrossRef] [PubMed]
  12. Goitia, H.; Villacampa, M.D.; Laguna, A.; Gimeno, M.C. Cytotoxic Gold(I) Complexes with Amidophosphine Ligands Containing Thiophene Moieties. Inorganics 2019, 7, 13–26. [Google Scholar] [CrossRef]
  13. Novakov, I.A.; Orlinson, B.S.; Navrotskii, M.B. Desulfurization of 2-Thioxo-1,2,3,4-tetrahydropyrimidin-4-ones with Oxiranes and 2-Haloacetonitriles. Russ. J. Org. Chem. 2005, 41, 607–609. [Google Scholar] [CrossRef]
  14. Golubyatnikova, L.G.; Khisamutdinov, R.A.; Grabovskii, S.A.; Kabal’nova, N.N.; Murinov, Y.I. Complexes of Palladium(II) and Platinum(II) with 6-tert-Butyl-2-thiouracil. Russ. J. Gen. Chem. 2017, 87, 117–121. [Google Scholar] [CrossRef]
  15. Shareena Dasari, T.P.; Zhang, Y.; Yu, H. Antibacterial Activity and Cytotoxicity of Gold(I) and (III) Ions and Gold Nanoparticles. Biochem. Pharmacol. 2015, 4, 199–203. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, Y.; Dasari, T.; Deng, H.; Yu, H. Antimicrobial Activity of Gold Nanoparticles and Ionic Gold. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2015, 3, 286–327. [Google Scholar] [CrossRef] [PubMed]
  17. Shaban, N.Z.; Masoud, M.S.; Awad, D.; Mawlawia, M.A.; Sadek, O.M. Effect of Cd, Zn and Hg complexes of barbituric acid and thiouracil on rat brain monoamine oxidase-B (in vitro). Chem.-Biol. Interact. 2014, 208, 37–46. [Google Scholar] [CrossRef] [PubMed]
  18. Lusty, J.R.; Peeling, J.; Abdel-Aal, M.A. Complexes of 6-Methyl-2-thiouracil with Rhodium, Iridium, Platinum and Palladium. Inorg. Chim. Acta 1981, 56, 21–26. [Google Scholar] [CrossRef]
  19. Teleb, S.M.; Askar, M.E.; El-Kalyoubi, S.A.; Gaballa, A.S. Synthesis, characterization and antimicrobial activities of some 5-bromouracil−metal ion complexes. Bull. Chem. Soc. Ethiop. 2019, 33, 255–268. [Google Scholar] [CrossRef]
Figure 1. Monodentate coordination of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one with one of the four donor atoms, without any prior deprotonation (the tautomeric form participates in N1- and N3-coordination).
Figure 1. Monodentate coordination of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one with one of the four donor atoms, without any prior deprotonation (the tautomeric form participates in N1- and N3-coordination).
Molbank 2024 m1827 g001
Figure 2. Monodentate coordination with deprotonated ligand who participate as a monoanionic (through a deprotonated nitrogen atom in the first position N1 or a nitrogen atom in the third position N3).
Figure 2. Monodentate coordination with deprotonated ligand who participate as a monoanionic (through a deprotonated nitrogen atom in the first position N1 or a nitrogen atom in the third position N3).
Molbank 2024 m1827 g002
Figure 3. Bidentate coordination with formed chelate.
Figure 3. Bidentate coordination with formed chelate.
Molbank 2024 m1827 g003
Figure 4. Possible bridge means of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one coordination with metal ions.
Figure 4. Possible bridge means of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one coordination with metal ions.
Molbank 2024 m1827 g004
Figure 5. 1H NMR spectrum of the gold complex in DMSO-d6 solution.
Figure 5. 1H NMR spectrum of the gold complex in DMSO-d6 solution.
Molbank 2024 m1827 g005
Figure 6. 13C NMR spectrum of the gold complex in DMSO-d6 solution.
Figure 6. 13C NMR spectrum of the gold complex in DMSO-d6 solution.
Molbank 2024 m1827 g006
Figure 7. 13C NMR acquired with MAS at 15 kHz. (A)—CP spectrum of the ligand; (B)—CP spectrum of the complex; (C)—CPPI spectrum of the complex.
Figure 7. 13C NMR acquired with MAS at 15 kHz. (A)—CP spectrum of the ligand; (B)—CP spectrum of the complex; (C)—CPPI spectrum of the complex.
Molbank 2024 m1827 g007
Figure 8. The representation of suggested coordination binding sites for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one.
Figure 8. The representation of suggested coordination binding sites for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one.
Molbank 2024 m1827 g008
Table 1. Selected experimental IR data (in KBr, wavenumber in cm−1) for 6-methyl-2-thiouracil (L) and its complex.
Table 1. Selected experimental IR data (in KBr, wavenumber in cm−1) for 6-methyl-2-thiouracil (L) and its complex.
AssignmentLAuL
ν(OH)-
ν(NH)3115 sh3109
ν(NH)30803089
ν(=CH)3014
ν(C=O)1676 m1642
1560 w1557
ν(C=S)12421272
1167 s1167
Table 2. Analytical and physical characteristic of metal complexes with 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L).
Table 2. Analytical and physical characteristic of metal complexes with 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L).
CompoundColourYield (%)Melting Point (°C)Solubility
Lcolorless 330soluble in DMSO
AuLyellow-orange56>350 °Climited solubility in DMSO and DMF;
insoluble in H2O, EtOH, THF, EtOAc and C6H12.
Table 3. 1H and 13C NMR spectral data and 1H-1H COSY and HMBC correlations for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (600.13 MHz (1H) and 150.903 MHz (13C)) a [8].
Table 3. 1H and 13C NMR spectral data and 1H-1H COSY and HMBC correlations for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (600.13 MHz (1H) and 150.903 MHz (13C)) a [8].
Atomδ (13C) ppmDEPT-135 δ (1H) ppmMultiplicity (J, Hz)1H-1H COSY HMBC
1 (NH) 12.29s
2 (C=S)175.87C
3 (NH) 12.29s
4 (C=O)161.06C
5103.72CH5.68d (0.9)1′4 b, 6, 1′
6153.20C
1′18.11CH32.06d (0.7)55, 6
(a) In DMSO-d6 solution. All these assignments were in agreement with COSY, HMQC and HMBC spectra. (b) These correlations are weak.
Table 4. 13C NMR spectral data in solution of complex and 1H of 6-methyl-uracil.
Table 4. 13C NMR spectral data in solution of complex and 1H of 6-methyl-uracil.
Atomδ (13C) ppm
6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One
δ (13C) ppm
AuL
δ (13C) ppm
6-MeU
δ (1H) ppm
6-MeU
1 (NH)---10.86
2 (C=S)/C=O175.87174.09151.43
3 (NH)---10.80
4 (C=O)161.06160.60163.98
5103.72104.8498.585.31
6153.20153.28152.74
1′18.1118.11 2.01
DMSO 40.31
Table 5. 13C spectral data (in ppm) for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L) and its complexes with Au(III) acquired with solid-state CP MAS.
Table 5. 13C spectral data (in ppm) for 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one (L) and its complexes with Au(III) acquired with solid-state CP MAS.
AtomLAuL
1 (NH)--
2 (C=S)174.6171.7; 173.6; 174.7
3 (NH)--
4 (C=O)163.0160.1; 162.0; 163.0; 166.5
5104.7100.4; 104.7; 108.9; 109.9; 111.5
6156.2154.3; 154.7; 156.3; 157.2; 157.8
1′20.219.3; 20.2; 20.4
DMSO-H6-40.7; 41.2
Table 6. Elemental analysis data for the metal ion of the complex.
Table 6. Elemental analysis data for the metal ion of the complex.
Metal ComplexComposition *FormulaMolecular WeightW(M)% calc./exp.
Au(III)L[4LAu].6-MeU.DMSO.16H2OC27H68N10O23S5AuM = 1258.17 g/mol15.7/16.2 ± 1.2
[4LAu]. 6-MeU.2DMSO.6H2OC29H54N10O14S6AuM = 1156.15 g/mol17.0/16.2 ± 1.2
[4LAu]. 6-MeU.2DMSO.5H2OC29H52N10O13S6AuM = 1138.14 g/mol17.3/16.2 ± 1.2
* Tentative average composition of different complexes.
Table 7. Antimicrobial activity of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its Au(III) complex.
Table 7. Antimicrobial activity of 6-methyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one and its Au(III) complex.
Test MicroorganismsDMSOCompounds
6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-OneAu(III)L
Inhibition Zone, mm
Staphylococcus aureus ATCC 25923--16
Escherichia coli ATCC 8739--8
Enterococcus faecalis ATCC 19433-1111
Salmonella enterica ssp. enterica ser. Enetritidis ATCC 13076--11
Pseudomonas aeruginosa ATCC 9027-99
Proteus vulgaris G-9 *-
Bacillus subtilis ATCC 6633-9 *8
Bacillus cereus ATCC 11778-9 *9
Listeria monocytogenes ATCC 8787-9 *-
Klebsiella pneumoniae ATCC 13883-9 *12 *
Candida albicans ATCC 10231-1110
Saccharomyces cerevisiae--8
Well diameter—7 mm. * Inhibition zone with single-cell colonies.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Marinova, P.; Burdzhiev, N.; Blazheva, D.; Slavchev, A. Synthesis and Antibacterial Studies of a New Au(III) Complex with 6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One. Molbank 2024, 2024, M1827. https://doi.org/10.3390/M1827

AMA Style

Marinova P, Burdzhiev N, Blazheva D, Slavchev A. Synthesis and Antibacterial Studies of a New Au(III) Complex with 6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One. Molbank. 2024; 2024(2):M1827. https://doi.org/10.3390/M1827

Chicago/Turabian Style

Marinova, Petya, Nikola Burdzhiev, Denica Blazheva, and Aleksandar Slavchev. 2024. "Synthesis and Antibacterial Studies of a New Au(III) Complex with 6-Methyl-2-Thioxo-2,3-Dihydropyrimidin-4(1H)-One" Molbank 2024, no. 2: M1827. https://doi.org/10.3390/M1827

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop